Copyright
|
Site Map
|
About Us
Products
Research
Clinical
News
Contact
Home
»
Press Releases
Media Contact
Events Calendar
News Alerts
Press Releases
August 5, 2008
Apthera and TGen Drug Development Services (TD2) Sign Master Services Agreement
June 2, 2008
Apthera’s NeuVax™ Produces Delays in Recurrence in High-Risk HER2-Positive Prostate Cancer Patients
April 14, 2008
Low HER2 Expressing Breast Cancer Patients Respond Preferentially to Apthera’s NeuVax™
October 31, 2007
Apthera Announces Completion of End of Phase II Meeting with the U.S. Food and Drug Administration for NeuVax™ for Breast Cancer
